Cleavage of transmembrane junction proteins and their role in regulating epithelial homeostasis

Tissue Barriers

Volumn 1, Issue 2, 2013, Pages

  Nava, Porfirio ^a,b   Kamekura, Ryuta ^a   Nusrat, Asma ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Cancer; Cleavage of junction proteins; Epithelia; Epithelial homeostasis; Inflammatory bowel disease; Intercellular junctions; Mucosal inflammation; Proteases; Protein shedding; Soluble junction protein ectodomains

Indexed keywords

ADAM10 ENDOPEPTIDASE; AEROLYSIN; CATHEPSIN B; CLAUDIN 2; DESMOCOLLIN; DESMOGLEIN 1; DESMOGLEIN 2; DESMOGLEIN 3; EPITHELIAL CELL ADHESION MOLECULE; FRAGILYSIN; GAMMA SECRETASE; GELATINASE A; GELATINASE B; JUNCTIONAL ADHESION MOLECULE A; KALLIKREIN 6; LEUKOCYTE ELASTASE; LYMPHOCYTE ANTIGEN; MATRILYSIN; MATRIPTASE; MEMBRANE PROTEIN; MEPRIN; NECTIN 1 ALPHA; NECTIN 4; OCCLUDIN; PLASMIN; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVOMORULIN;

APOPTOSIS; CELL ADHESION; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DESMOSOME; EPITHELIUM; HOMEOSTASIS AND REGULATION; HUMAN; INFLAMMATION; NEOPLASM; NONHUMAN; PROTEIN CLEAVAGE; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION; UPREGULATION;

EID: 85007361234     PISSN: 21688362     EISSN: 21688370     Source Type: Journal    
DOI: None     Document Type: Review

References (150)

1. Farquhar MG, Palade GE. Junctional complexes in various epithelia. J Cell Biol 1963; 17:375-412; PMID:13944428; http://dx.doi.org/10.1083/ jcb.17.2.375
2. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2:285-93; PMID:11283726; http://dx.doi. org/10.1038/35067088
3. Sawada N, Murata M, Kikuchi K, Osanai M, Tobioka H, Kojima T, et al. Tight junctions and human diseases. Med Electron Microsc 2003; 36:147-56; PMID:14505058; http://dx.doi.org/10.1007/s00795-003-0219-y
4. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004; 286:C1213-28; PMID:15151915; http://dx.doi. org/10.1152/ajpcell.00558.2003
5. Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S, Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 2005; 171:939-45; PMID:16365161; http://dx.doi. org/10.1083/jcb.200510043
6. Balda MS, Matter K. Tight junctions at a glance. J Cell Sci 2008; 121:3677-82; PMID:18987354; http:// dx.doi.org/10.1242/jcs.023887
7. Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol 2007; 127:2525-32; PMID:17934504; http://dx.doi. org/10.1038/sj.jid.5700865
8. Harris TJ, Tepass U. Adherens junctions: from molecules to morphogenesis. Nat Rev Mol Cell Biol 2010; 11:502-14; PMID:20571587; http://dx.doi. org/10.1038/nrm2927
9. Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science 2004; 303:1483-7; PMID:15001769; http://dx.doi.org/10.1126/science. 1094291
10. Brembeck FH, Rosário M, Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of β-catenin. Curr Opin Genet Dev 2006; 16:51-9; PMID:16377174; http://dx.doi.org/10.1016/j. gde.2005.12.007
11. Dusek RL, Godsel LM, Green KJ. Discriminating roles of desmosomal cadherins: beyond desmosomal adhesion. J Dermatol Sci 2007; 45:7-21; PMID:17141479; http://dx.doi.org/10.1016/j.jdermsci.2006.10.006
12. Holthöfer B, Windoffer R, Troyanovsky S, Leube RE. Structure and function of desmosomes. Int Rev Cytol 2007; 264:65-163; PMID:17964922; http://dx.doi. org/10.1016/S0074-7696(07)64003-0
13. Green KJ, Simpson CL. Desmosomes: new perspectives on a classic. J Invest Dermatol 2007; 127:2499-515; PMID:17934502; http://dx.doi.org/10.1038/ sj.jid.5701015
14. Nava P, Laukoetter MG, Hopkins AM, Laur O, Gerner-Smidt K, Green KJ, et al. Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol Biol Cell 2007; 18:4565-78; PMID:17804817; http:// dx.doi.org/10.1091/mbc.E07-05-0426
15. Jamora C, Fuchs E. Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol 2002; 4:E101-8; PMID:11944044; http://dx.doi.org/10.1038/ ncb0402-e101
16. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991; 67:869-77; PMID:1720352; http://dx.doi.org/10.1016/0092-8674(91)90360-B
17. Allen EM, Giudice GJ, Diaz LA. Subclass reactivity of pemphigus foliaceus autoantibodies with recombinant human desmoglein. J Invest Dermatol 1993; 100:685-91; PMID:8491991; http://dx.doi.org/10.1111/1523-1747.ep12472348
18. Waschke J. The desmosome and pemphigus. Histochem Cell Biol 2008; 130:21-54; PMID:18386043; http:// dx.doi.org/10.1007/s00418-008-0420-0
19. McCarthy KM, Francis SA, McCormack JM, Lai J, Rogers RA, Skare IB, et al. Inducible expression of claudin-1-myc but not occludin-VSV-G results in aberrant tight junction strand formation in MDCK cells. J Cell Sci 2000; 113:3387-98; PMID:10984430
20. Ivanov AI, Nusrat A, Parkos CA. Endocytosis of the apical junctional complex: mechanisms and possible roles in regulation of epithelial barriers. Bioessays 2005; 27:356-65; PMID:15770686; http://dx.doi. org/10.1002/bies.20203
21. Utech M, Ivanov AI, Samarin SN, Bruewer M, Turner JR, Mrsny RJ, et al. Mechanism of IFN-γ-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 2005; 16:5040-52; PMID:16055505; http://dx.doi.org/10.1091/mbc. E05-03-0193
22. Andersen NJ, Yeaman C. Sec3-containing exocyst complex is required for desmosome assembly in mammalian epithelial cells. Mol Biol Cell 2010; 21:152-64; PMID:19889837; http://dx.doi.org/10.1091/mbc. E09-06-0459
23. Rios-Doria J, Day KC, Kuefer R, Rashid MG, Chinnaiyan AM, Rubin MA, et al. The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J Biol Chem 2003; 278:1372-9; PMID:12393869; http://dx.doi. org/10.1074/jbc.M208772200
24. Kowalczyk AP, Nanes BA. Adherens junction turnover: regulating adhesion through cadherin endocytosis, degradation, and recycling. Subcell Biochem 2012; 60:197-222; PMID:22674073; http://dx.doi. org/10.1007/978-94-007-4186-7_9
25. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 2001; 13:534-40; PMID:11544020; http:// dx.doi.org/10.1016/S0955-0674(00)00248-9
26. Grabowska MM, Day ML. Soluble E-cadherin: more than a symptom of disease. Front Biosci 2012; 17:1948-64; PMID:22201848; http://dx.doi.org/10.2741/4031
27. Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, et al. A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 2002; 21:1948-56; PMID:11953314; http://dx.doi. org/10.1093/emboj/21.8.1948
28. Huet E, Vallée B, Delbé J, Mourah S, Prulière-Escabasse V, Tremouilleres M, et al. EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease. Am J Pathol 2011; 179:1278-86; PMID:21777561; http:// dx.doi.org/10.1016/j.ajpath.2011.05.036
29. Willemsen LE, Hoetjes JP, van Deventer SJ, van Tol EA. Abrogation of IFN-γ mediated epithelial barrier disruption by serine protease inhibition. Clin Exp Immunol 2005; 142:275-84; PMID:16232214; http:// dx.doi.org/10.1111/j.1365-2249.2005.02906.x
30. Wan H, Winton HL, Soeller C, Gruenert DC, Thompson PJ, Cannell MB, et al. Quantitative structural and biochemical analyses of tight junction dynamics following exposure of epithelial cells to house dust mite allergen Der p 1. Clin Exp Allergy 2000; 30:685-98; PMID:10792361; http://dx.doi. org/10.1046/j.1365-2222.2000.00820.x
31. Wu Z, Nybom P, Magnusson KE. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell Microbiol 2000; 2:11-7; PMID:11207559; http://dx.doi.org/10.1046/ j.1462-5822.2000.00025.x
32. Bücker R, Krug SM, Rosenthal R, Günzel D, Fromm A, Zeitz M, et al. Aerolysin from Aeromonas hydrophila perturbs tight junction integrity and cell lesion repair in intestinal epithelial HT-29/B6 cells. J Infect Dis 2011; 204:1283-92; PMID:21917902; http://dx.doi. org/10.1093/infdis/jir504
33. Runswick S, Mitchell T, Davies P, Robinson C, Garrod DR. Pollen proteolytic enzymes degrade tight junctions. Respirology 2007; 12:834-42; PMID:17986111; http://dx.doi.org/10.1111/j.1440-1843.2007.01175.x
34. Heijink IH, van Oosterhout A, Kapus A. Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction. Eur Respir J 2010; 36:1016-26; PMID:20351035; http:// dx.doi.org/10.1183/09031936.00125809
35. Koenen RR, Pruessmeyer J, Soehnlein O, Fraemohs L, Zernecke A, Schwarz N, et al. Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood 2009; 113:4799-809; PMID:19258599; http://dx.doi. org/10.1182/blood-2008-04-152330
36. Takai Y, Irie K, Shimizu K, Sakisaka T, Ikeda W. Nectins and nectin-like molecules: roles in cell adhesion, migration, and polarization. Cancer Sci 2003; 94:655-67; PMID:12901789; http://dx.doi. org/10.1111/j.1349-7006.2003.tb01499.x
37. Saito M, Tucker DK, Kohlhorst D, Niessen CM, Kowalczyk AP. Classical and desmosomal cadherins at a glance. J Cell Sci 2012; 125:2547-52; PMID:22833291; http://dx.doi.org/10.1242/jcs.066654
38. Le Bras GF, Taubenslag KJ, Andl CD. The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression. Cell Adh Migr 2012; 6:365-73; PMID:22796940; http://dx.doi. org/10.4161/cam.21326
39. Davies G, Jiang WG, Mason MD. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Cancer Res 2001; 7:3289-97; PMID:11595727
40. Noë V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001; 114:111-8; PMID:11112695
41. Symowicz J, Adley BP, Gleason KJ, Johnson JJ, Ghosh S, Fishman DA, et al. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Res 2007; 67:2030-9; PMID:17332331; http://dx.doi.org/10.1158/0008-5472.CAN-06-2808
42. Inge LJ, Barwe SP, D'Ambrosio J, Gopal J, Lu K, Ryazantsev S, et al. Soluble E-cadherin promotes cell survival by activating epidermal growth factor receptor. Exp Cell Res 2011; 317:838-48; PMID:21211535; http://dx.doi.org/10.1016/j.yexcr.2010.12.025
43. Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E, et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and β-catenin translocation. Proc Natl Acad Sci U S A 2005; 102:9182-7; PMID:15958533; http:// dx.doi.org/10.1073/pnas.0500918102
44. Hoy B, Geppert T, Boehm M, Reisen F, Plattner P, Gadermaier G, et al. Distinct roles of secreted HtrA proteases from gram-negative pathogens in cleaving the junctional protein and tumor suppressor E-cadherin. J Biol Chem 2012; 287:10115-20; PMID:22337879; http://dx.doi.org/10.1074/jbc.C111.333419
45. Wu S, Lim KC, Huang J, Saidi RF, Sears CL. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc Natl Acad Sci U S A 1998; 95:14979-84; PMID:9844001; http://dx.doi. org/10.1073/pnas.95.25.14979
46. Katz J, Yang QB, Zhang P, Potempa J, Travis J, Michalek SM, et al. Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains. Infect Immun 2002; 70:2512-8; PMID:11953390; http:// dx.doi.org/10.1128/IAI.70.5.2512-2518.2002
47. Lim ST, Chang A, Giuliano RE, Federoff HJ. Ectodomain shedding of nectin-1 regulates the maintenance of dendritic spine density. J Neurochem 2012; 120:741-51; PMID:22118475; http://dx.doi. org/10.1111/j.1471-4159.2011.07592.x
48. Tanaka Y, Irie K, Hirota T, Sakisaka T, Nakanishi H, Takai Y. Ectodomain shedding of nectin-1α by SF/ HGF and TPA in MDCK cells. Biochem Biophys Res Commun 2002; 299:472-8; PMID:12445825; http:// dx.doi.org/10.1016/S0006-291X(02)02681-5
49. Fabre-Lafay S, Garrido-Urbani S, Reymond N, Gonçalves A, Dubreuil P, Lopez M. Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-α-converting enzyme (TACE)/ADAM-17. J Biol Chem 2005; 280:19543-50; PMID:15784625; http://dx.doi.org/10.1074/jbc. M410943200
50. Simpson CL, Kojima S, Cooper-Whitehair V, Getsios S, Green KJ. Plakoglobin rescues adhesive defects induced by ectodomain truncation of the desmosomal cadherin desmoglein 1: implications for exfoliative toxin-mediated skin blistering. Am J Pathol 2010; 177:2921-37; PMID:21075858; http://dx.doi. org/10.2353/ajpath.2010.100397
51. Jiang R, Shi Z, Johnson JJ, Liu Y, Stack MS. Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma. J Biol Chem 2011; 286:9127-35; PMID:21163944; http://dx.doi. org/10.1074/jbc.M110.191361
52. Getsios S, Simpson CL, Kojima S, Harmon R, Sheu LJ, Dusek RL, et al. Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis. J Cell Biol 2009; 185:1243-58; PMID:19546243; http://dx.doi.org/10.1083/ jcb.200809044
53. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med 2000; 6:1275-7; PMID:11062541; http://dx.doi. org/10.1038/81385
54. Hanakawa Y, Schechter NM, Lin C, Garza L, Li H, Yamaguchi T, et al. Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome. J Clin Invest 2002; 110:53-60; PMID:12093888
55. Yang T, Liang D, Koch PJ, Hohl D, Kheradmand F, Overbeek PA. Epidermal detachment, desmosomal dissociation, and destabilization of corneodesmosin in Spink5-/-mice. Genes Dev 2004; 18:2354-8; PMID:15466487; http://dx.doi.org/10.1101/ gad.1232104
56. Descargues P, Deraison C, Bonnart C, Kreft M, Kishibe M, Ishida-Yamamoto A, et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 2005; 37:56-65; PMID:15619623
57. Wadhawan V, Kolhe YA, Sangith N, Gautam AK, Venkatraman P. From prediction to experimental validation: desmoglein 2 is a functionally relevant substrate of matriptase in epithelial cells and their reciprocal relationship is important for cell adhesion. Biochem J 2012; 447:61-70; PMID:22783993; http://dx.doi. org/10.1042/BJ20111432
58. Bech-Serra JJ, Santiago-Josefat B, Esselens C, Saftig P, Baselga J, Arribas J, et al. Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis. Mol Cell Biol 2006; 26:5086-95; PMID:16782893; http:// dx.doi.org/10.1128/MCB.02380-05
59. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17:463-516; PMID:11687497; http://dx.doi. org/10.1146/annurev.cellbio.17.1.463
60. Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 2010; 20:161-8; PMID:20470890; http://dx.doi.org/10.1016/j.semcancer. 2010.05.002
61. Wheelock MJ, Buck CA, Bechtol KB, Damsky CH. Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem 1987; 34:187-202; PMID:3611200; http://dx.doi.org/10.1002/ jcb.240340305
62. Ryniers F, Stove C, Goethals M, Brackenier L, Noë V, Bracke M, et al. Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion. Biol Chem 2002; 383:159-65; PMID:11928810; http://dx.doi. org/10.1515/BC.2002.016
63. Johnson SK, Ramani VC, Hennings L, Haun RS. Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin. Cancer 2007; 109:1811-20; PMID:17354228; http://dx.doi.org/10.1002/ cncr.22606
64. Afonso AA, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC. Tear fluid gelatinase B activity correlates with IL-1α concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 1999; 40:2506-12; PMID:10509643
65. Smith VA, Rishmawi H, Hussein H, Easty DL. Tear film MMP accumulation and corneal disease. Br J Ophthalmol 2001; 85:147-53; PMID:11159476; http://dx.doi.org/10.1136/bjo.85.2.147
66. Pflugfelder SC, Farley W, Luo L, Chen LZ, de Paiva CS, Olmos LC, et al. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol 2005; 166:61-71; PMID:15632000; http://dx.doi. org/10.1016/S0002-9440(10)62232-8
67. Wong V, Gumbiner BM. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 1997; 136:399-409; PMID:9015310; http://dx.doi. org/10.1083/jcb.136.2.399
68. Makagiansar IT, Avery M, Hu Y, Audus KL, Siahaan TJ. Improving the selectivity of HAV-peptides in modulating E-cadherin-E-cadherin interactions in the intercellular junction of MDCK cell monolayers. Pharm Res 2001; 18:446-53; PMID:11451030; http:// dx.doi.org/10.1023/A:1011094025008
69. Nava P, López S, Arias CF, Islas S, González-Mariscal L. The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells. J Cell Sci 2004; 117:5509-19; PMID:15494377; http://dx.doi.org/10.1242/jcs.01425
70. Mrsny RJ, Brown GT, Gerner-Smidt K, Buret AG, Meddings JB, Quan C, et al. A key claudin extracellular loop domain is critical for epithelial barrier integrity. Am J Pathol 2008; 172:905-15; PMID:18349130; http://dx.doi.org/10.2353/ajpath.2008.070698
71. Beyer I, van Rensburg R, Strauss R, Li Z, Wang H, Persson J, et al. Epithelial junction opener JO-1 improves monoclonal antibody therapy of cancer. Cancer Res 2011; 71:7080-90; PMID:21990319; http://dx.doi.org/10.1158/0008-5472.CAN-11-2009
72. Bendas G, Borsig L. Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol 2012; 2012:676731; PMID:22505933; http://dx.doi. org/10.1155/2012/676731
73. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 1997; 139:1861-72; PMID:9412478; http:// dx.doi.org/10.1083/jcb.139.7.1861
74. Xian W, Schwertfeger KL, Vargo-Gogola T, Rosen JM. Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model. J Cell Biol 2005; 171:663-73; PMID:16301332; http://dx.doi.org/10.1083/ jcb.200505098
75. Brouxhon SM, Kyrkanides S, Teng X, Athar M, Ghazizadeh S, Simon M, et al. Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling. Oncogene 2013; PMID:23318419; http://dx.doi.org/10.1038/ onc.2012.563
76. Nawrocki-Raby B, Gilles C, Polette M, Bruyneel E, Laronze JY, Bonnet N, et al. Upregulation of MMPs by soluble E-cadherin in human lung tumor cells. Int J Cancer 2003; 105:790-5; PMID:12767064; http:// dx.doi.org/10.1002/ijc.11168
77. Najy AJ, Day KC, Day ML. The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. J Biol Chem 2008; 283:18393-401; PMID:18434311; http://dx.doi.org/10.1074/jbc. M801329200
78. Fouquet S, Lugo-Martínez VH, Faussat AM, Renaud F, Cardot P, Chambaz J, et al. Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes. J Biol Chem 2004; 279:43061-9; PMID:15292248; http://dx.doi.org/10.1074/jbc. M405095200
79. Lanza A, Cirillo N. Caspase-dependent cleavage of desmoglein 1 depends on the apoptotic stimulus. Br J Dermatol 2007; 156:400-2; PMID:17223900; http:// dx.doi.org/10.1111/j.1365-2133.2006.07654.x
80. Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, Huber O. Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem 2001; 276:4972-80; PMID:11076937; http://dx.doi.org/10.1074/jbc. M006102200
81. Rios-Doria J, Day ML. Truncated E-cadherin potentiates cell death in prostate epithelial cells. Prostate 2005; 63:259-68; PMID:15538719; http://dx.doi. org/10.1002/pros.20179
82. Sumitomo T, Nakata M, Higashino M, Jin Y, Terao Y, Fujinaga Y, et al. Streptolysin S contributes to group A streptococcal translocation across an epithelial barrier. J Biol Chem 2011; 286:2750-61; PMID:21084306; http://dx.doi.org/10.1074/jbc.M110.171504
83. Chun J, Prince A. TLR2-induced calpain cleavage of epithelial junctional proteins facilitates leukocyte transmigration. Cell Host Microbe 2009; 5:47-58; PMID:19154987; http://dx.doi.org/10.1016/j. chom.2008.11.009
84. Ito K, Okamoto I, Araki N, Kawano Y, Nakao M, Fujiyama S, et al. Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of β-catenin from cell-cell contacts. Oncogene 1999; 18:7080-90; PMID:10597309; http://dx.doi.org/10.1038/ sj.onc.1203191
85. Cirillo N, Lanza M, De Rosa A, Cammarota M, La Gatta A, Gombos F, et al. The most widespread desmosomal cadherin, desmoglein 2, is a novel target of caspase 3-mediated apoptotic machinery. J Cell Biochem 2008; 103:598-606; PMID:17559062; http://dx.doi. org/10.1002/jcb.21431
86. Kolegraff K, Nava P, Laur O, Parkos CA, Nusrat A. Characterization of full-length and proteolytic cleavage fragments of desmoglein-2 in native human colon and colonic epithelial cell lines. Cell Adh Migr 2011; 5:306-14; PMID:21715983; http://dx.doi. org/10.4161/cam.5.4.16911
87. Zuckerman JD, Lee WY, DelGaudio JM, Moore CE, Nava P, Nusrat A, et al. Pathophysiology of nasal polyposis: the role of desmosomal junctions. Am J Rhinol 2008; 22:589-97; PMID:19178795; http:// dx.doi.org/10.2500/ajr.2008.22.3235
88. rd, et al. A role for caveolin-1 in desmoglein binding and desmosome dynamics. Oncogene 2012; 31:1636-48; PMID:21841821; http://dx.doi. org/10.1038/onc.2011.346
89. Brennan D, Hu Y, Joubeh S, Choi YW, Whitaker-Menezes D, O'Brien T, et al. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes. J Cell Sci 2007; 120:758-71; PMID:17284515; http:// dx.doi.org/10.1242/jcs.03392
90. Raurell I, Codina M, Casagolda D, Del Valle B, Baulida J, de Herreros AG, et al. Gamma-secretasedependent and-independent effects of presenilin1 on β-catenin. Tcf-4 transcriptional activity. PLoS One 2008; 3:e4080; PMID:19114997; http://dx.doi. org/10.1371/journal.pone.0004080
91. Ferber EC, Kajita M, Wadlow A, Tobiansky L, Niessen C, Ariga H, et al. A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus. J Biol Chem 2008; 283:12691-700; PMID:18356166; http:// dx.doi.org/10.1074/jbc.M708887200
92. Jang C, Choi JK, Na YJ, Jang B, Wasco W, Buxbaum JD, et al. Calsenilin regulates presenilin 1/γ-secretasemediated N-cadherin ε-cleavage and β-catenin signaling. FASEB J 2011; 25:4174-83; PMID:21852538; http://dx.doi.org/10.1096/fj.11-185926
93. Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, et al. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol 2009; 11:162-71; PMID:19136966; http://dx.doi.org/10.1038/ncb1824
94. Utton MA, Eickholt B, Howell FV, Wallis J, Doherty P. Soluble N-cadherin stimulates fibroblast growth factor receptor dependent neurite outgrowth and N-cadherin and the fibroblast growth factor receptor co-cluster in cells. J Neurochem 2001; 76:1421-30; PMID:11238727; http://dx.doi.org/10.1046/j.1471-4159.2001.00140.x
95. Reddy P, Liu L, Ren C, Lindgren P, Boman K, Shen Y, et al. Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells. Mol Endocrinol 2005; 19:2564-78; PMID:15928314; http://dx.doi. org/10.1210/me.2004-0342
96. Lampugnani MG, Orsenigo F, Gagliani MC, Tacchetti C, Dejana E. Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol 2006; 174:593-604; PMID:16893970; http://dx.doi.org/10.1083/ jcb.200602080
97. Kang HG, Jenabi JM, Zhang J, Keshelava N, Shimada H, May WA, et al. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res 2007; 67:3094-105; PMID:17409416; http://dx.doi.org/10.1158/0008-5472.CAN-06-3259
98. Pittard AJ, Banks RE, Galley HF, Webster NR. Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndrome. Br J Anaesth 1996; 76:629-31; PMID:8688260; http://dx.doi.org/10.1093/ bja/76.5.629
99. Katayama M, Hirai S, Kamihagi K, Nakagawa K, Yasumoto M, Kato I. Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 1994; 69:580-5; PMID:8123491; http://dx.doi. org/10.1038/bjc.1994.106
100. Sewpaul A, French JJ, Khoo TK, Kernohan M, Kirby JA, Charnley RM. Soluble E-cadherin: an early marker of severity in acute pancreatitis. HPB Surg 2009; 2009:397375; PMID:19421334; http://dx.doi. org/10.1155/2009/397375
101. Doyle JL, Haas TL. Differential role of b-catenin in VEGF and histamine-induced MMP-2 production in microvascular endothelial cells. J Cell Biochem 2009; 107:272-83; PMID:19306293; http://dx.doi. org/10.1002/jcb.22123
102. He W, Tan RJ, Li Y, Wang D, Nie J, Hou FF, et al. Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD. J Am Soc Nephrol 2012; 23:294-304; PMID:22095947; http:// dx.doi.org/10.1681/ASN.2011050490
103. van Kempen LC, de Visser KE, Coussens LM. Inflammation, proteases and cancer. Eur J Cancer 2006; 42:728-34; PMID:16524717; http://dx.doi. org/10.1016/j.ejca.2006.01.004
104. Chung Y, Law S, Kwong DL, Luk JM. Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma. Dis Esophagus 2011; 24:49-55; PMID:20807231; http://dx.doi. org/10.1111/j.1442-2050.2010.01093.x
105. Derycke L, De Wever O, Stove V, Vanhoecke B, Delanghe J, Depypere H, et al. Soluble N-cadherin in human biological fluids. Int J Cancer 2006; 119:2895-900; PMID:16998833; http://dx.doi.org/10.1002/ ijc.22219
106. Griffiths TR, Brotherick I, Bishop RI, White MD, McKenna DM, Horne CH, et al. Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence. Br J Cancer 1996; 74:579-84; PMID:8761373; http://dx.doi. org/10.1038/bjc.1996.404
107. Protheroe AS, Banks RE, Mzimba M, Porter WH, Southgate J, Singh PN, et al. Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer. Br J Cancer 1999; 80:273-8; PMID:10390008; http://dx.doi. org/10.1038/sj.bjc.6690351
108. Wilmanns C, Grossmann J, Steinhauer S, Manthey G, Weinhold B, Schmitt-Gräff A, et al. Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients. Clin Exp Metastasis 2004; 21:75-8; PMID:15065605; http://dx.doi.org/10.1023/ B:CLIN.0000017204.38807.22
109. Weiss JV, Klein-Scory S, Kübler S, Reinacher-Schick A, Stricker I, Schmiegel W, et al. Soluble E-cadherin as a serum biomarker candidate: elevated levels in patients with late-stage colorectal carcinoma and FAP. Int J Cancer 2011; 128:1384-92; PMID:20473926; http:// dx.doi.org/10.1002/ijc.25438
110. Chan AO, Lam SK, Chu KM, Lam CM, Kwok E, Leung SY, et al. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut 2001; 48:808-11; PMID:11358900; http://dx.doi.org/10.1136/ gut.48.6.808
111. Soyama A, Eguchi S, Takatsuki M, Kawashita Y, Hidaka M, Tokai H, et al. Significance of the serum level of soluble E-cadherin in patients with HCC. Hepatogastroenterology 2008; 55:1390-3; PMID:18795696
112. Charalabopoulos K, Gogali A, Dalavaga Y, Daskalopoulos G, Vassiliou M, Bablekos G, et al. The clinical significance of soluble E-cadherin in nonsmall cell lung cancer. Exp Oncol 2006; 28:83-5; PMID:16614715
113. Gogali A, Charalabopoulos K, Zampira I, Konstantinidis AK, Tachmazoglou F, Daskalopoulos G, et al. Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers. Chest 2010; 138:1173-9; PMID:20495107; http://dx.doi.org/10.1378/chest.10-0157
114. Sundfeldt K, Ivarsson K, Rask K, Haeger M, Hedin L, Brännström M. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts. Anticancer Res 2001; 21(1A):65-70; PMID:11299791
115. Gil OD, Lee C, Ariztia EV, Wang FQ, Smith PJ, Hope JM, et al. Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner. Gynecol Oncol 2008; 108:361-9; PMID:18073130; http://dx.doi. org/10.1016/j.ygyno.2007.10.027
116. Kuefer R, Hofer MD, Zorn CS, Engel O, Volkmer BG, Juarez-Brito MA, et al. Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer. Br J Cancer 2005; 92:2018-23; PMID:15870707; http://dx.doi.org/10.1038/ sj.bjc.6602599
117. Billion K, Ibrahim H, Mauch C, Niessen CM. Increased soluble E-cadherin in melanoma patients. Skin Pharmacol Physiol 2006; 19:65-70; PMID:16685144; http://dx.doi.org/10.1159/000091972
118. Shirahama S, Furukawa F, Wakita H, Takigawa M. Eand P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer. J Dermatol Sci 1996; 13:30-6; PMID:8902651; http:// dx.doi.org/10.1016/0923-1811(95)00493-9
119. Velikova G, Banks RE, Gearing A, Hemingway I, Forbes MA, Preston SR, et al. Serum concentrations of soluble adhesion molecules in patients with colorectal cancer. Br J Cancer 1998; 77:1857-63; PMID:9667659; http://dx.doi.org/10.1038/bjc.1998.309
120. Gadducci A, Ferdeghini M, Cosio S, Annicchiarico C, Ciampi B, Bianchi R, et al. Preoperative serum E-cadherin assay in patients with ovarian carcinoma. Anticancer Res 1999; 19(1B):769-72; PMID:10216491
121. Manetti M, Guiducci S, Romano E, Rosa I, Ceccarelli C, Mello T, et al. Differential expression of junctional adhesion molecules in different stages of systemic sclerosis. Arthritis Rheum 2013; 65:247-57; PMID:23001478; http://dx.doi.org/10.1002/ art.37712
122. Streeck H, Kwon DS, Pyo A, Flanders M, Chevalier MF, Law K, et al. Epithelial adhesion molecules can inhibit HIV-1-specific CD8+ T-cell functions. Blood 2011; 117:5112-22; PMID:21403126; http://dx.doi. org/10.1182/blood-2010-12-321588
123. Nishifuji K, Shimizu A, Ishiko A, Iwasaki T, Amagai M. Removal of amino-terminal extracellular domains of desmoglein 1 by staphylococcal exfoliative toxin is sufficient to initiate epidermal blister formation. J Dermatol Sci 2010; 59:184-91; PMID:20728315; http://dx.doi.org/10.1016/j.jdermsci.2010.07.010
124. Schnell U, Kuipers J, Giepmans BN. EpCAM proteolysis: new fragments with distinct functions? Biosci Rep 2013; 33:e00030; PMID:23409978; http://dx.doi. org/10.1042/BSR20120128
125. Casas E, Barron C, Francis SA, McCormack JM, McCarthy KM, Schneeberger EE, et al. Cholesterol efflux stimulates metalloproteinase-mediated cleavage of occludin and release of extracellular membrane particles containing its C-terminal fragments. Exp Cell Res 2010; 316:353-65; PMID:19854171; http://dx.doi. org/10.1016/j.yexcr.2009.10.020
126. Zeng R, Li X, Gorodeski GI. Estrogen abrogates transcervical tight junctional resistance by acceleration of occludin modulation. J Clin Endocrinol Metab 2004; 89:5145-55; PMID:15472219; http://dx.doi. org/10.1210/jc.2004-0823
127. Gorodeski GI. Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occludin. Endocrinology 2007; 148:218-31; PMID:17038551; http://dx.doi. org/10.1210/en.2006-1120
128. Biswas MH, Du C, Zhang C, Straubhaar J, Languino LR, Balaji KC. Protein kinase D1 inhibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase-9 secretion in prostate cancer. Cancer Res 2010; 70:2095-104; PMID:20160036; http://dx.doi.org/10.1158/0008-5472.CAN-09-4155
129. Lynch CC, Vargo-Gogola T, Matrisian LM, Fingleton B. Cleavage of E-Cadherin by Matrix Metalloproteinase-7 Promotes Cellular Proliferation in Nontransformed Cell Lines via Activation of RhoA. J Oncol 2010; 2010:530745; PMID:20628524; http:// dx.doi.org/10.1155/2010/530745
130. McGuire JK, Li Q, Parks WC. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 2003; 162:1831-43; PMID:12759241; http://dx.doi. org/10.1016/S0002-9440(10)64318-0
131. Lee KH, Choi EY, Hyun MS, Jang BI, Kim TN, Kim SW, et al. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells. Eur Surg Res 2007; 39:208-15; PMID:17396032; http://dx.doi. org/10.1159/000101452
132. Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ, et al. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem 2011; 112:2508-17; PMID:21557297; http://dx.doi. org/10.1002/jcb.23175
133. Huguenin M, Müller EJ, Trachsel-Rösmann S, Oneda B, Ambort D, Sterchi EE, et al. The metalloprotease meprinb processes E-cadherin and weakens intercellular adhesion. PLoS One 2008; 3:e2153; PMID:18478055; http://dx.doi.org/10.1371/journal.pone.0002153
134. Maretzky T, Scholz F, Köten B, Proksch E, Saftig P, Reiss K. ADAM10-mediated E-cadherin release is regulated by proinflammatory cytokines and modulates keratinocyte cohesion in eczematous dermatitis. J Invest Dermatol 2008; 128:1737-46; PMID:18200054; http://dx.doi.org/10.1038/sj.jid.5701242
135. Schirrmeister W, Gnad T, Wex T, Higashiyama S, Wolke C, Naumann M, et al. Ectodomain shedding of E-cadherin and c-Met is induced by Helicobacter pylori infection. Exp Cell Res 2009; 315:3500-8; PMID:19665015; http://dx.doi.org/10.1016/j. yexcr.2009.07.029
136. Solanas G, Cortina C, Sevillano M, Batlle E. Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nat Cell Biol 2011; 13:1100-7; PMID:21804545; http://dx.doi. org/10.1038/ncb2298
137. Frank CF, Hostetter MK. Cleavage of E-cadherin: a mechanism for disruption of the intestinal epithelial barrier by Candida albicans. Transl Res 2007; 149:211-22; PMID:17383595; http://dx.doi.org/10.1016/j. trsl.2006.11.006
138. Klucky B, Mueller R, Vogt I, Teurich S, Hartenstein B, Breuhahn K, et al. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion. Cancer Res 2007; 67:8198-206; PMID:17804733; http://dx.doi.org/10.1158/0008-5472.CAN-07-0607
139. Mayerle J, Schnekenburger J, Krüger B, Kellermann J, Ruthenbürger M, Weiss FU, et al. Extracellular cleavage of E-cadherin by leukocyte elastase during acute experimental pancreatitis in rats. Gastroenterology 2005; 129:1251-67; PMID:16230078; http://dx.doi. org/10.1053/j.gastro.2005.08.002
140. Gocheva V, Zeng W, Ke D, Klimstra D, Reinheckel T, Peters C, et al. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 2006; 20:543-56; PMID:16481467; http://dx.doi. org/10.1101/gad.1407406
141. Dusek RL, Getsios S, Chen F, Park JK, Amargo EV, Cryns VL, et al. The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. J Biol Chem 2006; 281:3614-24; PMID:16286477; http://dx.doi. org/10.1074/jbc.M508258200
142. Lundström A, Egelrud T. Evidence that cell shedding from plantar stratum corneum in vitro involves endogenous proteolysis of the desmosomal protein desmoglein I. J Invest Dermatol 1990; 94:216-20; PMID:1688905; http://dx.doi.org/10.1111/1523-1747.ep12874531
143. Klessner JL, Desai BV, Amargo EV, Getsios S, Green KJ. EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2. Mol Biol Cell 2009; 20:328-37; PMID:18987342; http://dx.doi.org/10.1091/mbc. E08-04-0356
144. Santiago-Josefat B, Esselens C, Bech-Serra JJ, Arribas J. Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors. J Biol Chem 2007; 282:8325-31; PMID:17227756; http://dx.doi.org/10.1074/jbc. M608826200
145. Ramani VC, Hennings L, Haun RS. Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer. BMC Cancer 2008; 8:373; PMID:19091121; http://dx.doi. org/10.1186/1471-2407-8-373
146. Weiske J, Schöneberg T, Schröder W, Hatzfeld M, Tauber R, Huber O. The fate of desmosomal proteins in apoptotic cells. J Biol Chem 2001; 276:41175-81; PMID:11500511; http://dx.doi.org/10.1074/jbc. M105769200
147. Covington MD, Burghardt RC, Parrish AR. Ischemiainduced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am J Physiol Renal Physiol 2006; 290:F43-51; PMID:16077081; http://dx.doi. org/10.1152/ajprenal.00179.2005
148. Yoo CB, Yun SM, Jo C, Koh YH. γ-Secretasedependent cleavage of E-cadherin by staurosporine in breast cancer cells. Cell Commun Adhes 2012; 19:11-6; PMID:22401168; http://dx.doi.org/10.3109/15419 061.2012.665969
149. Schmeiser K, Grand RJ. The fate of E-and P-cadherin during the early stages of apoptosis. Cell Death Differ 1999; 6:377-86; PMID:10381631; http://dx.doi. org/10.1038/sj.cdd.4400504
150. Kim DY, Ingano LA, Kovacs DM. Nectin-1α, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/γ-secretase-like cleavage. J Biol Chem 2002; 277:49976-81; PMID:12376527; http://dx.doi.org/10.1074/jbc. M210179200